当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3492151
已选条件
-
T80621Semzuvolimab;化合物 SemzuvolimabUB421;UB421
Semzuvolimab, a murine IgG1κ antibody, targets the p55 T-cell surface antigen T4/Leu-3 (CD4). It has demonstrated capabilities to neutralize HIV infection and may inhibit HIV in patients on stable highly active antiretroviral therapy (HAART) [1] [2].
价 格:¥电议型 号:T80621产 地:中国大陆
-
T80619Rosnilimab;化合物 RosnilimabANB030;ANB030
Rosnilimab is a humanized IgG1-κ antibody that targets PD-1 [1] [2].
价 格:¥电议型 号:T80619产 地:中国大陆
-
T80617Reozalimab;化合物 ReozalimabReozalimab
Rezilimab is a bispecific antibody that targets PD-1/PD-L1 and mediates antibody-dependent cell cytotoxicity (ADCC) in cancer research [1] [2].
价 格:¥电议型 号:T80617产 地:中国大陆
-
T80616Posdinemab;化合物 PosdinemabPosdinemab
Posdinemab, a humanized IgG1κ antibody, targets the microtubule-associated protein tau (MAPT) [1].
价 格:¥电议型 号:T80616产 地:中国大陆
-
T80615Enoticumab;化合物 EnoticumabREGN421;REGN421
Enoticumab (REGN421, SAR153192) is an IgG1κ antibody that specifically targets human Delta-like ligand 4 (Dll4), which serves as a crucial component of the Notch signaling pathway and regulates the uptake of fatty acids through non-transcriptional modulation of macropinocytosis-dependent long-chain fatty acid absorption. Demonstrated efficacy in vivo, Enoticumab was shown to inhibit tumor growth by 86% and 83% in subcutaneous TOV-112D and intraperitoneal A2780 human ovarian tumor xenograft mouse
价 格:¥电议型 号:T80615产 地:中国大陆
-
T80614Serclutamab;化合物 SerclutamabDC-1630423|||PR-1594407;DC-1630423|||PR-1594407
Serclutamab, a humanized chimeric monoclonal antibody of the IgG1-κ isotype, selectively targets the epidermal growth factor receptor (EGFR). It is primarily produced in Chinese Hamster Ovary (CHO) cells [1].
价 格:¥电议型 号:T80614产 地:中国大陆
-
T80613Linvoseltamab;化合物 LinvoseltamabREGN5458;REGN5458
Linvoseltamab, a bispecific antibody, targets both BCMA (TNFRSF17) and CD3 epsilon, demonstrating a favorable safety profile and promising efficacy in relapsed/refractory multiple myeloma (RRMM) [1][2].
价 格:¥电议型 号:T80613产 地:中国大陆
-
T80612Pimurutamab;化合物 PimurutamabPimurutamab
Pimurutamab, a humanized IgG1-κ antibody, selectively targets the epidermal growth factor receptor (EGFR) and is primarily produced by CHO-K1 cells [1].
价 格:¥电议型 号:T80612产 地:中国大陆
-
T80611Sasanlimab;化合物 SasanlimabPF-06801591;PF-06801591
Sasanlimab (PF-06801591), a humanized IgG4-κ antibody, selectively targets PD-1 and is primarily produced in Chinese Hamster Ovary (CHO) cells [1].
价 格:¥电议型 号:T80611产 地:中国大陆
-
T80610Romilkimab;化合物 RomilkimabSAR156597;SAR156597
Romilkimab (SAR156597) is a chimeric humanized immunoglobulin (Ig) antibody designed to specifically target interleukins 4 and 13 (IL-4 and IL-13) [1].
价 格:¥电议型 号:T80610产 地:中国大陆
-
T80609Mecbotamab;化合物 MecbotamabMecbotamab
Mecbotamab vedotin (BA3011) is a humanized IgG1-κ antibody engineered to target the AXL receptor tyrosine kinase (AXL). Serving as a conditionally active biologic (CAB), mecbotamab is conjugated to monomethyl auristatin E (MMAE) through a cleavable linker, creating an antibody-drug conjugate (ADC) for therapeutic use [1] [2].
价 格:¥电议型 号:T80609产 地:中国大陆
-
T80608Ebronucimab;化合物 EbronucimabAK102;AK102
Ebronucimab (AK102), an IgG1-λ2 antibody, specifically targets PCSK9 and is predominantly produced in CHO DG44 (Chinese Hamster Ovary) cells [1].
价 格:¥电议型 号:T80608产 地:中国大陆
-
T80607Eblasakimab;化合物 EblasakimabCSL-334|||ASLAN004;CSL-334|||ASLAN004
Eblasakimab (also known as ASLAN004 or CSL-334) is a human IgG4 monoclonal antibody that selectively binds to IL13RA1, and is predominantly produced in CHO-K1 cells [1].
价 格:¥电议型 号:T80607产 地:中国大陆
-
T80606Duvortuxizumab;化合物 DuvortuxizumabMGD 011;MGD 011
Duvortuxizumab (MGD 011) is a chimeric, humanized immunoglobulin (IG) antibody that specifically targets CD19 and CD3E receptors [1].
价 格:¥电议型 号:T80606产 地:中国大陆
-
T80605Dusigitumab;化合物 DusigitumabMEDI 573;MEDI 573
Dusigitumab (MEDI 573) is a human IgG2λ monoclonal antibody targeting the insulin-like growth factors IGF2 and IGF1, offering therapeutic potential for conditions related to these proteins [1].
价 格:¥电议型 号:T80605产 地:中国大陆
-
T80604Duligotuzumab;化合物 DuligotuzumabRG 7597|||MEHD-7945A;RG 7597|||MEHD-7945A
Duligotuzumab (MEHD-7945A; RG 7597) is a humanized IgG-κ monoclonal antibody targeting Her3 (ErbB3) [1].
价 格:¥电议型 号:T80604产 地:中国大陆
-
T80603Dresbuxelimab;化合物 DresbuxelimabAK-119;AK-119
Dresbuxelimab (AK-119), an IgG-κ monoclonal antibody, selectively targets CD73 and is commonly produced using a Chinese Hamster Ovary (CHO) cell expression system [1].
价 格:¥电议型 号:T80603产 地:中国大陆
-
T80602Dovanvetmab;化合物 DovanvetmabZTS-00521505;ZTS-00521505
Dovanvetmab (ZTS-00521505) is an IgG1-κ monoclonal antibody that targets feline interleukin 31 (Felcat IL31), primarily produced in Chinese Hamster Ovary (CHO) cells [1].
价 格:¥电议型 号:T80602产 地:中国大陆
-
T80599Dectrekumab;德屈库单抗QAX576;QAX576
Dectrekumab (QAX576), a humanized monoclonal antibody targeting IL-13, significantly reduces intraepithelial esophageal eosinophil counts and normalizes dysregulated esophageal disease-related transcripts in Eosinophilic esophagitis (EoE), offering sustained benefits. It is valuable for inflammation and immunology research [1].
价 格:¥电议型 号:T80599产 地:中国大陆
-
T80597Dafsolimab;化合物 DafsolimabSPV-T3a;SPV-T3a
Dafsolimab (SPV-T3a), an IgG2a murine monoclonal antibody (anti-CD3), induces cell death by modulating and activating the CD3/T cell receptor complex and is utilized in research pertaining to graft-versus-host disease (GVHD) [1].
价 格:¥电议型 号:T80597产 地:中国大陆